A Study to Compare the Pharmacokinetics of Different Formulations of AZD9977 and the Influence of Food in Healthy Male Subjects

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
PharmacokineticsHealthy Male SubjectsSafetyFood Effect
Interventions
DRUG

AZD9977 immediate release (IR) oral suspension

120 mg (4.8 mL x 25 mg/mL) oral suspension, single dose

DRUG

AZD9977 extended release (ER) capsules [fast]

120 mg (2 x 60mg capsules) single dose

DRUG

AZD9977 extended release (ER) capsules [intermediate]

120 mg (2 x 60mg capsules) single dose

DRUG

AZD9977 extended release (ER) capsules [slow]

120 mg (2 x 60mg capsules) single dose

Trial Locations (1)

Unknown

Research Site, Harrow

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY